Conventional neuroleptics and rehabilitation in schizophrenic patients

被引:1
|
作者
Colonna, L
机构
[1] CHS du Rouvray, Service Hospitalo-Universitaire, 76301 Sotteville-les-Rouen Cedex
关键词
schizophrenia; rehabilitation; neuroleptics; relapses; hospitalisation;
D O I
10.1016/0924-9338(96)84747-X
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Nowadays, the rehabilitation of schizophrenic patients is a major issue for psychiatry. Regarding the role of conventional neuroleptics, the following points will be considered in this paper: the role of neuroleptics in the number, length and frequency of hospitalisations; the role of neuroleptics in the number, degree and length of relapses; the clinical effects of neuroleptics, focusing particularly on their disinhibitory action, the most controversial and least studied of the clinical effects of these drugs; and the side effects, which have been intensively studied and particularly criticised during these last years, leading to the development of new drugs discussed in the next article. All the published data relating to the psychosocial profile of schizophrenic patients clearly demonstrate the need for further research in order to improve the familial social and professional rehabilitation of these patients.
引用
收藏
页码:S71 / S76
页数:6
相关论文
共 50 条
  • [1] Atypical neuroleptics: Their contribution to the rehabilitation of schizophrenic patients
    Vanelle, JM
    Brochier, T
    Bayle, FJ
    Loo, H
    [J]. EUROPEAN PSYCHIATRY, 1996, 11 : S85 - S89
  • [2] Conventional and atypical neuroleptics and neurological soft signs in schizophrenic patients
    Bersani, G
    Gherardelli, S
    Pancheri, P
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 199 - 199
  • [3] Stereotypy in schizophrenic patients on atypical antipsychotics versus conventional neuroleptics
    Morrens, M.
    Hulstijn, W.
    Sabbe, B. G. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S392 - S393
  • [4] Conventional versus atypical neuroleptics: Subjective quality of life in schizophrenic patients
    Franz, M
    Lis, S
    Pluddemann, K
    Gallhofer, B
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 : 422 - 425
  • [5] Atypical neuroleptics in the treatment of schizophrenic patients
    Finzen, A
    [J]. PSYCHIATRISCHE PRAXIS, 2002, 29 (02) : 100 - 100
  • [6] Clozapine and its metabolites plasma concentrations and clinical response in schizophrenic patients resistant to conventional neuroleptics
    Llorca, PM
    Langon, C
    Auquier, P
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 254 - 254
  • [7] NEUROLEPTICS AND CYTOKINE PRODUCTION IN SCHIZOPHRENIC-PATIENTS
    PIANCATELLI, D
    DELBEATO, T
    PELLEGRINI, P
    DIMICHELE, V
    CASACCHIA, M
    ADORNO, D
    CASCIANI, CU
    [J]. EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1993, 13 (01): : 107 - 108
  • [8] Effect of neuroleptics on social dysfunctions in schizophrenic patients
    Mahé, V
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2003, 29 : S28 - S30
  • [9] Driving ability in schizophrenic patients:: effects of neuroleptics
    Soyka, M
    Kagerer, S
    Brunnauer, A
    Laux, G
    Möller, HJ
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2005, 9 (03) : 168 - 174
  • [10] Rehabilitation of schizophrenic patients
    Gunatilake, S
    Ananth, J
    Parameswaran, S
    Brown, S
    Silva, W
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (18) : 2277 - 2288